Copyright © 2003 by the European Society of Cardiology.
Regular Articles
Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry
Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands
* Correspondence to: Anton P.M. Gorgels, Department of Cardiology, Cardiovascular Research Institute Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Tel: 0031 433875101; Fax: 0031 433875104
E-mail address: gorgels{at}cardio.azm.nl
Received 7 November 2002; revised 2 March 2003; accepted 14 March 2003
Aims To describe the incidence and aetiology of heart failure in out-of-hospital sudden circulatory arrest (SCA) in the Maastricht area of the Netherlands.
Methods All cases of SCA were studied in the age group 20 to 75 years between 1 January 1997 and 31 December 2000. Demographic characteristics, aetiology and clinical features, related to heart failure were studied.
Results Four hundred and ninety-two patients were included (72% men), mean age of 62±10. The yearly incidence of SCA was 9.2/10000 inhabitants. Sudden death represented 19% of all deaths, occurring in the same time period. In 52% of the men and 59% of women, SCA was the first manifestation of heart disease. In the SCA group with a cardiac history overt heart failure was present in 26% of the cases, the time interval between the first heart failure episode and SCA being 4.3±6.3 year. In the heart failure group the majority had previously been in a poor functional class and LVEF. Concerning aetiology, of the SCA group, 77% were known with CAD and 72% with an old MI. Also in the group with a LVEF >50% CAD was the most frequent cause.
Conclusions There is an increased risk of SCA at poorer pump function and most SCA victims with previous heart failure are in a poor functional class SCA. However heart failure is seen in only a minority of the SCA population. CAD is by far the most common cause of SCA.
Key Words: Sudden death • Heart failure • Population based • Incidence • Aetiology
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Pascale, J. Schlaepfer, M. Oddo, M.-D. Schaller, P. Vogt, and M. Fromer Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization Europace, October 28, 2009; (2009) eup314v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Chugh, K. Reinier, T. Singh, A. Uy-Evanado, C. Socoteanu, D. Peters, R. Mariani, K. Gunson, and J. Jui Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study Circulation, February 10, 2009; 119(5): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Albert Prediction of Sudden Cardiac Death in Patients With Coronary Heart Disease: The Challenge Ahead Circ Cardiovasc Imaging, November 1, 2008; 1(3): 175 - 177. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. de Sousa, C. A. Morillo, F. T. Rabelo, A. M. N. Filho, and A. L.P. Ribeiro Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis Eur J Heart Fail, October 1, 2008; 10(10): 1007 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. S. Fernandes, K. C. Wu, B. D. Rosen, A. Schmidt, A. C. Lardo, N. Osman, H. R. Halperin, G. Tomaselli, R. Berger, D. A. Bluemke, et al. Enhanced Infarct Border Zone Function and Altered Mechanical Activation Predict Inducibility of Monomorphic Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy Radiology, December 1, 2007; 245(3): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Buxton, K. L. Lee, G. E. Hafley, L. A. Pires, J. D. Fisher, M. R. Gold, M. E. Josephson, M. H. Lehmann, E. N. Prystowsky, and for the MUSTT Investigators Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease: Lessons From the MUSTT Study J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1150 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators Circulation, May 8, 2007; 115(18): 2451 - 2457. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Middelkamp, V. R. Moulaert, J. A Verbunt, C. M van Heugten, W. G. Bakx, and D. T. Wade Life after survival: long-term daily life functioning and quality of life of patients with hypoxic brain injury as a result of a cardiac arrest Clinical Rehabilitation, May 1, 2007; 21(5): 425 - 431. [Abstract] [PDF]
|
|
|
|
|
|
E. C. Stecker, C. Vickers, J. Waltz, C. Socoteanu, B. T. John, R. Mariani, J. H. McAnulty, K. Gunson, J. Jui, and S. S. Chugh Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction: Two-Year Findings from the Oregon Sudden Unexpected Death Study J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1161 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Groh Lessons From a Population: The Limitations of Left Ventricular Ejection Fraction as the Major Determinant for Primary Prevention Implantable Cardioverter-Defibrillators J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1167 - 1168. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Anand, A. N Mooss, and S. M Mohiuddin Review: Aldosterone Inhibition Reduces the Risk of Sudden Cardiac Death in Patients with Heart Failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 15 - 19. [Abstract] [PDF]
|
|
|
|
 |
|
 A. E. Buxton Sudden Death after Myocardial Infarction -- Who Needs Prophylaxis, and When? N. Engl. J. Med., June 23, 2005; 352(25): 2638 - 2640. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Circulation, May 17, 2005; 111(19): 2537 - 2549. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori From trials to guidelines to clinical practice: the need for improvement Europace, January 1, 2004; 6(3): 176 - 178. [Full Text] [PDF]
|
|